'RIGHT TIME, RIGHT PRODUCT': Credit Suisse analyst Dan Levy initiated coverage of Fisker ($FSR) with an Outperform rating and $32 price target in a research note titled "Right Time, Right Product, Right Path." With electric vehicle uptake "sharply inflecting" and the market lacking sufficient model options, Fisker offers a compelling value proposition with a sleek product at a high-volume price point, Levy told investors in a research note. The analyst believes the company is "leveraging a de-risked business strategy" and can accelerate development speed and path to scaled production while also unlocking lower price points. SELL SMILEDIRECTCLUB: Craig-Hallum analyst Alexander Nowak downgraded SmileDirectClub ($SDC) to Sell from Hold with a price target of $3, down from $8. As a follow up to a "disappointing" second quarter, the company delivered an "even worse Q3," Nowak contended. The analyst noted that while SmileDirectClub has had some difficult earnings results in the past, this quarter every metric went backwards and there is no visibility to the operating model. The biggest challenge on the go-forward is the company did not offer a definitive solution, he added. AMID BETTER EXECUTION: Guggenheim analyst Laurent Grandet upgraded J.M. Smucker ($SJM) to Buy from Neutral with a price target of $146, up from $136, as he is starting to see a positive outcome from multiple changes undertaken in the last two years that is bringing an improved operational focus. Grandet thinks growth is getting more favorable in both coffee and pet and sees Uncrustables as "an underappreciated growth driver." Further, the analyst argues that Smucker has built more margin protection from cost inflation than food peers. BEST POSITIONED U.S. PURE PLAY: Credit Suisse analyst Meghan Durkin upgraded Cinemark Holdings ($CNK) to Outperform from Neutral with a price target of $25, up from $16. The analyst views Cinemark as the best positioned U.S. pure play theater operator as the box office recovery "ramps up" into 2022. Cinemark has gained share post COVID, and given its affordable pricing and superior experience, the company's North American box office share should sustain at 14%, Durkin told investors in a research note. BUY REALREAL: BTIG analyst Marvin Fong upgraded RealReal ($REAL) to Buy from Neutral with a $21 price target after its third quarter earnings beat. Concerns over the company's path to breakeven should dissipate and allow investors to appreciate the improving fundamentals, the analyst contended. Fong added that RealReal management is taking the topic of EBITDA profitability "by the horns," committing to providing a timeline to profitability sometime in 2022. The analyst further stated that while Matt Gustke was an excellent CFO, his successor Robert Julian will also be a good steward of the company's finances.Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .